Before a drug manufacturer can permanently add warnings to a drug label, the Food and Drug Administration (“FDA”) must approve the addition. In Re Fosamax Alendronate Sodium Prods. Liab. Litig.. There are two different ways to implement this change....
failure-to-warn
(LIIBULLETIN preview (pre-2014))
Oral argument: Mar. 30, 2011
Appealed from: United States Court of Appeals for the Eighth Circuit (Nov. 27, 2009); United States Court of Appeals for the Fifth Circuit (Jan. 8, 2010)
DRUGS, FAILURE-TO-WARN,...